| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/27/1993 | WO1993009769A1 Methods and compositions utilizing pure s(+) isomer fluoxetine |
| 05/27/1993 | CA2123234A1 Synthesis and purification of truncated and mutein forms of human ciliary neuronotrophic factor |
| 05/27/1993 | CA2121835A1 N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists |
| 05/27/1993 | CA2083622A1 Certain macrocyclic lactam derivatives |
| 05/27/1993 | CA2083570A1 Combination having a neuroprotective effect |
| 05/27/1993 | CA2083440A1 Urea fusion process for the synthesis of 3-phenoxy-1-azetidinecarboxamides |
| 05/26/1993 | EP0543780A2 Novel aminoalkanephosphinic acids and their salts |
| 05/26/1993 | EP0543584A1 Benzo(b)thiophene-2-carboxamides for the treatment of disorders of the central nervous system |
| 05/26/1993 | EP0543088A1 Preparation and use of salts of the pure enantiomers of alpha-lipoic acid |
| 05/26/1993 | EP0542971A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-$g(b) SUPERFAMILY |
| 05/26/1993 | EP0542920A1 Cannabinoid receptor |
| 05/26/1993 | EP0542892A1 Chimeric neurotrophic factors |
| 05/26/1993 | EP0542846A1 N-hydrocarbyl-4-substituted piperidines, their preparation and use as calcium blocking agents |
| 05/26/1993 | EP0542844A1 3-substituted piperidine derivatives |
| 05/26/1993 | EP0542814A1 Neuroprotection by indolactam v and derivatives thereof |
| 05/26/1993 | CN1072411A Therapeutically active compound |
| 05/26/1993 | CN1020924C Production of pluripotent granule cell colony stimulating factor |
| 05/26/1993 | CA2082462A1 Azole derivatives |
| 05/26/1993 | CA2082333A1 Heterocyclic compounds |
| 05/26/1993 | CA2082332A1 Chemical process |
| 05/25/1993 | US5214180 Plant extracts, protecting hydroxy groups, solvent extraction, chromatography |
| 05/25/1993 | US5214060 Pyridylalkylpiperidine or pyrolidine |
| 05/25/1993 | US5214040 Side effect reduction |
| 05/25/1993 | US5214038 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof |
| 05/25/1993 | CA1318253C Stabilized pergolide compositions |
| 05/23/1993 | WO1993010102A1 Novel compounds having a guanidine structure and pharmaceutical composition containing same |
| 05/23/1993 | CA2101058A1 Novel compounds having a guanidine structure and pharmaceutical composition containing same |
| 05/22/1993 | CA2083307A1 Aminoalkanephosphinic acids and salts thereof |
| 05/19/1993 | EP0542671A1 Substituted hydroquinone derivatives as intermediates of benzofuran derivatives |
| 05/19/1993 | EP0542609A1 3-sulfonylamino-2-(1H)-quinolinones and 7-aza derivatives as excitatory amino acids antagonists |
| 05/19/1993 | EP0542364A1 Controlled release device |
| 05/19/1993 | EP0542136A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 05/19/1993 | EP0541798A1 New diamine compound and brain protecting agent containing the same |
| 05/19/1993 | EP0541757A1 NEW HETERO-ARYLOXY-$g(b)-CARBOLINES, THEIR PREPARATION AND THEIR USE IN MEDICAMENTS |
| 05/19/1993 | EP0541686A1 Tachykinin agonists for treatment of alzheimer's disease |
| 05/19/1993 | CN1020723C Process for 4-phenyl-4-(n-(phenyl) amido) piperidine derivatives |
| 05/19/1993 | CA2082839A1 Pharmaceutical compounds |
| 05/18/1993 | US5212188 Method for treatment of neurodegenerative diseases |
| 05/18/1993 | US5212181 Cerebral disorders |
| 05/18/1993 | US5212176 Adrenergic blockers |
| 05/18/1993 | US5212173 Alkylaminoalkylamine and ether compounds, processes and intermediates for their preparation, and medicaments containing them |
| 05/18/1993 | US5212169 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods for treating pain |
| 05/18/1993 | US5212158 Nootropic agents |
| 05/18/1993 | CA1317959C 5-(_-ammonio acyloxy methylene) tetrahydrofurans and tetrahydrothiophenes |
| 05/18/1993 | CA1317956C Basic-substituted 5-halo-thienoisothiazol-3(2h)-one 1, 1-dioxides, a process for the preparation thereof, and pharmaceutical preparations containing these compounds |
| 05/18/1993 | CA1317955C 3-¬4(1-substituted-4-piperazinyl)butyl|-4- thiazolidinones a process for their preparation and their use as medicaments |
| 05/18/1993 | CA1317945C Tricyclic pyridazopyridone derivatives |
| 05/18/1993 | CA1317944C 2-amino-4-morpholino-6-propyl-1,3,5-triazines |
| 05/18/1993 | CA1317938C Benzazapin derivatives |
| 05/15/1993 | CA2082856A1 3-sulfonylamino-2-(1h)-quinoleinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 05/14/1993 | CA2055378A1 Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide |
| 05/13/1993 | WO1993009122A1 Cns active tetrahydrobenzothienopyridines |
| 05/13/1993 | WO1993009105A1 Substituted dibenzoxazepine compounds as analgesic agents |
| 05/13/1993 | WO1993009104A1 10-acyl-dibenz(b,f) (1,4)-oxazepines and their thiazepines analo gues useful as prostaglandin antagonists |
| 05/13/1993 | WO1993009102A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 05/13/1993 | WO1993009095A1 2-heterocyclicethylamine derivatives and their use as pharmaceuticals |
| 05/13/1993 | WO1993008820A1 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 05/13/1993 | WO1993008819A1 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 05/13/1993 | WO1993008800A1 Potassium channel activating compounds and methods of use thereof |
| 05/13/1993 | CA2124856A1 Potassium channel activating compounds and methods of use thereof |
| 05/13/1993 | CA2122599A1 Ether derivatives of alkyl piperidines and pyrrolidines as antipsychotic agents |
| 05/13/1993 | CA2118688A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 05/13/1993 | CA2114211A1 Substituted dibenzoxazepine compounds as analgesic agents |
| 05/12/1993 | EP0541407A1 Nitrogen containing bicyclic derivatives, method for their preparation and pharmaceutical compositions containing them |
| 05/12/1993 | EP0540767A1 Treatment of lyso paf-mediated diseases with paf antagonists and procedure for determining their efficacy |
| 05/12/1993 | EP0540757A1 Water-based recording ink |
| 05/12/1993 | EP0540738A1 Remedy for sleep apnea |
| 05/12/1993 | EP0540625A1 Novel spiro-isoxazolidine derivatives as cholinergic agents |
| 05/12/1993 | EP0540576A1 Psychoactive drug and treatment |
| 05/12/1993 | CN1071922A Benzanilide derivatives |
| 05/12/1993 | CN1071919A Benzanilide derivatives |
| 05/12/1993 | CN1071916A 2,3-phthalazine containing ether or sulfide group at 1-position and process for preparing same |
| 05/12/1993 | CN1071915A Synthetic heteroaryl polyamines as exitatory amino acid neurotransmitter antagonists |
| 05/12/1993 | CN1071913A Tramadol n-oxide material, enantiomers and compositions thereof, and their use |
| 05/12/1993 | CN1071835A Composition comprising tramadol material and any of codeine, oxycodone or hydrocodone and their use |
| 05/11/1993 | US5210276 Phenylethanolamino- and phenylethanolaminomethyl-tetralines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| 05/11/1993 | US5210185 Preparing active beta subunit by homogenizing human placenta tissue, centrifuging homogenate, recovering supernatant, dialyzing to dissociate 7S NGF form, fractionating by cation exchange chromatography, purifying, polyclonal antibodies |
| 05/11/1993 | US5210099 Analgesic compositions |
| 05/11/1993 | US5210087 Cognition Activators |
| 05/11/1993 | US5210082 Treating panic disorder |
| 05/11/1993 | US5210076 Methods of treating Parkinson's disease using melanin |
| 05/11/1993 | US5210026 Human mk gene and method of expression |
| 05/11/1993 | CA1317593C Method of ameliorating epileptic seizures |
| 05/11/1993 | CA1317590C 2-substituted-e-fused-¬1,2,4|triazolo¬1,5- c|pyrimidines, pharmaceutical compositions, and uses thereof |
| 05/11/1993 | CA1317549C Analgesic containing a pyrimidine derivative |
| 05/06/1993 | DE4234933A1 New phthalazine derivs. |
| 05/05/1993 | EP0540318A1 2-Heterocyclicethylamine derivatives and their use as pharmaceuticals |
| 05/05/1993 | EP0539977A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and their use as analgesic agents and prostaglandin antagonists |
| 05/05/1993 | EP0539806A1 Thiadiazinones and medicines containing them, having in particular a positive inotropic and vasodilating activity |
| 05/05/1993 | EP0539805A1 Phthalazines substituted on position 1 by an ether or a thioether group and process for their preparation |
| 05/05/1993 | EP0539803A1 Triazospirodecanone-methyl-chromans for the treatment of central nervous system illnesses |
| 05/05/1993 | EP0539492A1 Antigenic iron repressible proteins from n. meningitidis related to the hemolysin family of toxins |
| 05/05/1993 | EP0539380A1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses |
| 05/05/1993 | CN1071665A Oxazolidone derivative |
| 05/05/1993 | CN1071585A Methods of treatment of motor neuron diseases using members of bdnf/nt-3/ngf family of molecule |
| 05/05/1993 | CA2081808A1 Combination of calcium antagonists with cholinesterase inhibitors |
| 05/04/1993 | US5208255 Thioester enantiomeric compounds and their therapeutic uses |
| 05/04/1993 | US5208246 Tetralones with pharmacological activity |
| 05/04/1993 | US5208240 8-substituted purines as selective adenosine receptor agents |
| 05/04/1993 | US5208035 Water Soluble Polymer Base, Penetration Enhancing Agent |